4//SEC Filing
ORAMED PHARMACEUTICALS INC. 4
Accession 0001213900-16-011555
$ORMPCIK 0001176309operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 2:38 PM ET
Size
5.9 KB
Accession
0001213900-16-011555
Insider Transaction Report
Form 4
JACOB HAROLD
Director
Transactions
- Sale
Common Stock
2016-03-10$6.45/sh−8,500$54,842→ 16,396 total
Holdings
- 700(indirect: By wholly-owned corporation)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.41 to $6.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001176309
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 2:38 PM ET
- Size
- 5.9 KB